214 related articles for article (PubMed ID: 24835198)
1. Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives.
Xu S; Li D; Pei L; Yao H; Wang C; Cai H; Yao H; Wu X; Xu J
Bioorg Med Chem Lett; 2014 Jul; 24(13):2811-4. PubMed ID: 24835198
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives.
Xu S; Pei L; Li D; Yao H; Cai H; Yao H; Wu X; Xu J
Fitoterapia; 2014 Dec; 99():300-6. PubMed ID: 25316557
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
Srivastav NC; Shakya N; Bhavanam S; Agrawal A; Tse C; Desroches N; Kunimoto DY; Kumar R
Bioorg Med Chem Lett; 2012 Jan; 22(2):1091-4. PubMed ID: 22178557
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antituberculosis activity of novel unfolded and macrocyclic derivatives of ent-kaurane steviol.
Khaybullin RN; Strobykina IY; Dobrynin AB; Gubaydullin AT; Chestnova RV; Babaev VM; Kataev VE
Bioorg Med Chem Lett; 2012 Nov; 22(22):6909-13. PubMed ID: 23046964
[TBL] [Abstract][Full Text] [Related]
6. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
8. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
[TBL] [Abstract][Full Text] [Related]
11. Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities.
Cheng W; Huang C; Ma W; Tian X; Zhang X
Mini Rev Med Chem; 2019; 19(2):114-124. PubMed ID: 28425866
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
Mohan Krishna K; Inturi B; Pujar GV; Purohit MN; Vijaykumar GS
Eur J Med Chem; 2014 Sep; 84():516-29. PubMed ID: 25055342
[TBL] [Abstract][Full Text] [Related]
14. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
15. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Pagadala LR; Mukkara LD; Singireddi S; Singh A; Thummaluru VR; Jagarlamudi PS; Guttala RS; Perumal Y; Dharmarajan S; Upadhyayula SM; Ummanni R; Basireddy VS; Ravirala N
Eur J Med Chem; 2014 Sep; 84():118-26. PubMed ID: 25016370
[TBL] [Abstract][Full Text] [Related]
17. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
[TBL] [Abstract][Full Text] [Related]
18. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria.
Wube AA; Bucar F; Hochfellner C; Blunder M; Bauer R; Hüfner A
Eur J Med Chem; 2011 Jun; 46(6):2091-101. PubMed ID: 21429630
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives.
Feng LS; Liu ML; Wang B; Chai Y; Hao XQ; Meng S; Guo HY
Eur J Med Chem; 2010 Aug; 45(8):3407-12. PubMed ID: 20493593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
